George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Regulatory News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Major Holdings

5 Mar 2019 07:00

RNS Number : 8084R
ReNeuron Group plc
05 March 2019
 

TR-1: Standard form for notification of major holdings

 

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

ReNeuron Group PLC

LEI: 2138003TU12CQ5TZO137

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Details of person subject to the notification obligation

Name

Invesco Ltd.

City and country of registered office (if applicable)

1555 Peachtree Street NE, Suite 1800,

Atlanta, GA 30309 United States

4. Full name of shareholder(s) (if different from 3.)

Name

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached:

01-03-2019

6. Date on which issuer notified (DD/MM/YYYY):

04-03-2019

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

9.89%

0

9.89%

31,646,186

Position of previous notification (if

applicable)

11.91%

0

11.91%

 

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

 

GB00BF5G6K95

Number of voting rights

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

 

 

3,132,955

 

9.89%

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

3,132,955

9.89%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdat

Exercise/Conversion Period 

Physical or cash

settlement

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)

X

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Invesco Asset

Management Ltd.

9.89%

0

9.89%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

Invesco (UK) Ltd.

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

 

11. Additional information

 

     

 

Place of completion

Henley-on-Thames

Date of completion

04-03-2019

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUGUUCWUPBGBC
Date   Source Headline
26th Mar 20137:00 amRNSApprovals for Stem Cell Trial in CLI
19th Mar 20134:40 pmRNSSecond Price Monitoring Extn
19th Mar 20134:35 pmRNSPrice Monitoring Extension
11th Mar 20137:00 amRNSWins Two Biomedical Catalyst Grants
6th Mar 20134:35 pmRNSPrice Monitoring Extension
25th Feb 20137:00 amRNSAIM Rule 17 Notification
29th Jan 20137:00 amRNSStroke Trial Update: Final Cohort Begins Dosing
11th Jan 20134:40 pmRNSSecond Price Monitoring Extn
11th Jan 20134:35 pmRNSPrice Monitoring Extension
4th Dec 20127:01 amRNSReNeuron to Present at UK Stroke Forum
4th Dec 20127:00 amRNSInterim Results
22nd Nov 20127:00 amRNSNon-Clinical Data
21st Nov 20127:00 amRNSNotification of Interim Results
17th Oct 20127:00 amRNSFurther Progress with Stroke Trial
21st Sep 201212:39 pmRNSTR-1: Notification of Major Interest in Shares
14th Sep 201210:00 amRNSDirectors' Interest in Shares and Share Options
11th Sep 201210:38 amRNSResults of 2012 Annual General Meeting
11th Sep 20127:00 amRNSAGM Trading Update
14th Aug 20127:00 amRNSStroke Trial Update
7th Aug 20129:42 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
16th Jul 20127:00 amRNSPosting of Annual Report & Notice of AGM
5th Jul 20124:40 pmRNSSecond Price Monitoring Extn
5th Jul 20124:35 pmRNSPrice Monitoring Extension
28th Jun 20127:01 amRNSSSAG and Non-Executive Board Changes
28th Jun 20127:00 amRNSPreliminary Results
19th Jun 20127:00 amRNSNotification of Preliminary Results
15th Jun 20127:00 amRNSPresents Further Data
14th Jun 20127:00 amRNSPISCES Trial Interim Data
8th Jun 201210:13 amRNSNotice of Major Interest in Shares
21st May 20127:00 amRNSPresentation at World Stem Cells Congress
16th May 20127:00 amRNSCell Manufacturing Contract
11th May 201211:09 amRNSNotifications of Major Interests in Shares
8th May 201210:52 amRNSTR-1: Notification of Major Interest in Shares
3rd May 201212:21 pmRNSAdmission of Open Offer Shares
27th Apr 20123:37 pmRNSTR-1: Notification of Major Interest in Shares
27th Apr 20123:26 pmRNSTR-1: Notification of Major Interest in Shares
27th Apr 20127:00 amRNSResult of Placing and Open Offer
20th Apr 20122:54 pmRNSResult of General Meeting
20th Apr 20127:00 amRNSInvestor Conference
19th Apr 201210:16 amRNSNotification of Major Interest in Shares
3rd Apr 20127:00 amRNSPlacing and Open Offer
30th Mar 20127:00 amRNSIssue of Ordinary Shares
27th Mar 20127:00 amRNSExercise of Warrants
17th Jan 20127:00 amRNSWebcast and content of Stem Cell Technical Seminar
11th Jan 201212:20 pmRNSChange of Adviser and Broker
11th Jan 20127:00 amRNSStability of lead stem cell line
9th Jan 201210:00 amRNSReNeuron to present at US healthcare conference
9th Jan 20127:00 amRNSNotification of Stem Cell Technical Seminar
3rd Jan 20127:00 amRNSData confirms pre-clinical efficacy of ReN001
19th Dec 20114:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.